Canavalia ensiformis supplement protects bladder from oxidative stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chemical-induced cystitis, such as that caused by protamine sulfate and uric acid, leads to bladder damage and inflammation due to oxidative stress, resulting in frequent urination and decreased bladder compliance, for which existing treatments are inadequate.
Innovation Solution
Administration of a Canavalia ensiformis supplement, which contains urease and concanavalin A, to protect the bladder from damage and prevent frequent urination by reducing oxidative stress and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If protamine sulfate and uric acid are administered for therapeutic purposes, then treatment efficacy is achieved, but bladder damage and inflammation occur due to oxidative stress
Solution Approach 1:
The patent applies preliminary anti-action by administering antioxidants (such as vitamin C, vitamin E, or other antioxidant compounds) before or concurrently with protamine sulfate and uric acid treatment. This preemptive measure neutralizes oxidative stress before it can cause bladder urothelium damage, thereby maintaining treatment efficacy while preventing the harmful inflammatory effects.
2Reliability
If chemical agents are used to treat bladder conditions, then therapeutic effect is achieved, but bladder compliance and capacity decrease
Solution Approach 1:
The patent employs preliminary action by protecting the bladder urothelium with antioxidants before chemical agents cause damage. This preparatory protection maintains the structural integrity and functional properties of the bladder, including compliance and capacity, while still allowing the chemical therapeutic agents to exert their intended effect on the bladder condition.
3Reliability
If oxidative stress is increased to enhance treatment effect, then therapeutic efficacy improves, but inflammation and bladder damage worsen
Solution Approach 1:
The patent introduces antioxidants as intermediary substances that mediate between the chemical therapeutic agents and the bladder tissue. These intermediaries scavenge reactive oxygen species and free radicals generated during treatment, thereby allowing the therapeutic agents to maintain their efficacy while preventing the accumulation of oxidative stress that would otherwise lead to inflammation and tissue damage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Canavalia ensiformis supplement effectively prevents bladder damage and maintains bladder compliance and capacity, as demonstrated by reduced contractile dysfunctions and increased antioxidant activity, indicating protection against protamine-uric acid induced cystitis.
Implementation Method 1
One of the major etiologies of the damage to the urothelium in chemical-induced models of cystitis is oxidative stress. Natural products showing antioxidant activity in several types of chemical cystitis have been shown to be effective in their treatment.
Data Source
AI summary
The present invention is related to a method for protection of bladder from damage, and prevention of frequent urination using a Canavalia ensiformis supplement.